Agilent Technologies, Inc. (NYSE:A) Raises Dividend to $0.26 Per Share

Agilent Technologies, Inc. (NYSE:A – Get Free Report) declared a quarterly dividend on Wednesday, November 18th. Shareholders of record on Tuesday, January 5th will be given a dividend of $0.2625 per share by the medical research company on Wednesday, January 27th. This represents a $1.05 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, January 5th. This is a 2.9% increase from Agilent Technologies’s previous quarterly dividend of $0.2550.

Agilent Technologies has raised its dividend payment by an average of 0.1% annually over the last three years and has raised its dividend annually for the last 9 consecutive years. Agilent Technologies has a dividend payout ratio of 16.9% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Agilent Technologies to earn $6.75 per share next year, which means the company should continue to be able to cover its $1.02 annual dividend with an expected future payout ratio of 15.1%.

Agilent Technologies Stock Up 2.9%

A opened at $177.15 on Thursday. The business has a 50 day moving average price of $170.01 and a two-hundred day moving average price of $138.80. Agilent Technologies has a 52 week low of $108.35 and a 52 week high of $182.99. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. The company has a market cap of $49.94 billion, a PE ratio of 34.87, a P/E/G ratio of 2.53 and a beta of 1.24.

Agilent Technologies (NYSE:A – Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.13. The company had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. Agilent Technologies’s revenue was up 8.1% compared to the same quarter last year. During the same period in the previous year, the company posted $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, research analysts anticipate that Agilent Technologies will post 6.20 EPS for the current year.

Insiders Place Their Bets

In related news, Director Mikael Dolsten sold 634 shares of Agilent Technologies stock in a transaction on Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the completion of the transaction, the director directly owned 4,924 shares of the company’s stock, valued at approximately $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 0.17% of the stock is owned by insiders.

Institutional Trading of Agilent Technologies

Several large investors have recently bought and sold shares of A. State Street Corp boosted its position in shares of Agilent Technologies by 1.0% in the 3rd quarter. State Street Corp now owns 12,979,038 shares of the medical research company’s stock worth $2,236,418,000 after buying an additional 124,808 shares in the last quarter. Wellington Management Group LLP increased its holdings in Agilent Technologies by 2.7% during the 2nd quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock valued at $990,206,000 after acquiring an additional 198,253 shares in the last quarter. Deutsche Bank AG increased its holdings in Agilent Technologies by 17.1% during the 2nd quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock valued at $930,957,000 after acquiring an additional 1,024,516 shares in the last quarter. Bank of New York Mellon Corp raised its position in Agilent Technologies by 87.4% during the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after acquiring an additional 2,440,360 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in Agilent Technologies by 9.6% during the first quarter. Dimensional Fund Advisors LP now owns 2,108,764 shares of the medical research company’s stock worth $240,336,000 after acquiring an additional 185,223 shares during the last quarter. Institutional investors and hedge funds own 87.41% of the company’s stock.

Agilent Technologies Company Profile

(Get Free Report)

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research. The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.

Featured Articles

Dividend History for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.